Details
Zusammenfassung: <jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Neural stem cells (NSCs) transplantation is considered a promising treatment for Parkinson's disease. But most NSCs are differentiated into glial cells rather than neurons, and only a few of them survive after transplantation due to the inflammatory environment.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>In this study, neural stem cells (NSCs) and microglial cells both forced with the <jats:italic>Nurr1</jats:italic> gene were transplanted into the striatum of the rat model of PD. The results were evaluated through reverse transcription polymerase chain reaction (RT‐PCR), Western blot, and immunofluorescence analysis.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The behavioral abnormalities of PD rats were improved by combined transplantation of NSCs and microglia, both forced with <jats:italic>Nurr1</jats:italic>. The number of tyrosine hydroxylase+ cells in the striatum of PD rats increased, and the number of Iba1+ cells decreased compared with the other groups. Moreover, the dopamine neurons differentiated from grafted NSCs could still be detected in the striatum of PD rats after 5 months.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>The results suggested that transplantation of Nurr1‐overexpressing NSCs and microglia could improve the inhospitable host brain environments, which will be  a new potential strategy for the cell replacement therapy in PD.</jats:p></jats:sec>
Umfang: 55-65
ISSN: 1755-5930
1755-5949
DOI: 10.1111/cns.13149